Who responds best to CagriSema Ideal candidates: Significant obesity (BMI 30-40+) Previously plateaued on GLP-1s alone Need maximum weight loss Good GI tolerability Metabolic syndrome or diabetes Commitment to long-term use Excellent responders: Higher baseline weight (more to lose) Good adherence to protocol Combine with diet/exercise Younger patients (better metabolism) No significant medication interactions May respond less optimally: Very low starting weight (BMI 30%): Nausea (most common) Decreased appetite (intended effect) Constipation Fatigue (especially first months) Common (10-30%): Vomiting (if nausea not managed) Diarrhea (alternating with constipation) Abdominal pain/discomfort Headache Dizziness Less common ( 40 with comorbidities Insurance covers surgery Want permanent solution Don't want ongoing injections Sourcing cagrilintide and semaglutide Obtaining these peptides requires understanding current availability
Hydrating, non-sensitizing ingredients like squalane, glycerin, and plant extracts to support skin barrier health
This peptide is chemically stable, highly resistant to degradation, and exhibits biological activity across various cell types, including those found in muscular, tendon, nervous, and gastrointestinal tissues.globalrph+4
Glutathione can help support the elimination of toxins and chemicals encountered through daily living.*
Pinch about an inch of skin and fat
Vitamin B 12 may be more effective than nortriptyline in improving painful diabetic neuropathy
